Average Co-Inventor Count = 7.18
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (109 from 4,945 patents)
2. Other (1 from 832,843 patents)
3. Genentech, Inc. (1 from 3,222 patents)
4. C4 Therapeutics, Inc. (1 from 32 patents)
5. C4 Therepeutics, Inc. (1 from 1 patent)
6. F. Hoffmann-la Roche Ag (168 patents)
113 patents:
1. 12479849 - EGFR inhibitors for the treatment of cancer
2. 12344613 - EGFR inhibitor for the treatment of cancer
3. 12281124 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
4. 12227504 - Spirocyclic compounds
5. 12209091 - Isoindolinone derivatives as selective allosteric inhibitors of Egfr mutant cancers
6. 11981661 - Heterocyclic compounds
7. 11814375 - Heterocyclic compounds
8. 11802133 - Heterocyclic compounds as monoacylglycerol lipase inhibitors
9. 11708354 - 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds
10. 11608347 - Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
11. 11584748 - Spirocyclic compounds
12. 11420961 - Heterocyclic compounds
13. 11390610 - Piperazine derivatives as MAGL inhibitors
14. 11117890 - Substituted isoindole allosteric EGFR inhibitors
15. 10882848 - 2-benzopyrazinyl-n-heteroaryl-2-phenyl-acetamide compounds